Clinical Research Directory
Browse clinical research sites, groups, and studies.
Use of Blinded Tapering for Hypnotic Discontinuation
Sponsor: National Jewish Health
Summary
The study will employ a randomized longitudinal clinical trial design to evaluate the relative efficacy of a blinded hypnotic tapering protocol when used in combination with therapist delivered Cognitive Behavioral Therapy for Insomnia (CBTI) for enhancing hypnotic discontinuation rates. A blinded SMT+CBTI intervention will be compared to open-label SMT+CBTI.
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
260
Start Date
2019-12-16
Completion Date
2026-06-30
Last Updated
2025-02-24
Healthy Volunteers
No
Interventions
Hypnotic Medication Open-Label Taper
Participants will have their soporific hypnotic medication dosage reduced by 25% every two weeks during a 10 week open-label tapering period.
Hypnotic Medication Blinded Taper
Participants will have their soporific hypnotic medication dosage reduced by 25% every two weeks during a 10 week blinded tapering period.
Locations (1)
National Jewish Health
Denver, Colorado, United States